Haberler/Reuters/Curevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechCurevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechRefinitivOkuma süresi: 1 dakikadan kısaCVACGSKPFEBNTXCurevac CVAC said on Thursday that the company and GSK GSK have entered an agreement to resolve patent dispute with Pfizer PFE and BioNTech BNTX over mRNA-based COVID-19 vaccines. ABD hisseleriAlmanya hisseleriAvrupaBK hisseleriFinansal tablolarReuters© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlDaha fazla gösterBu haberi okumak için giriş yapın veya sonsuza kadar ücretsiz bir hesap oluşturunGidelim
